Dr. Núria Pedreño Lopez graduated in Microbiology at the Autonomous University of Barcelona (UAB) in 2013. In 2014, she obtained a Master's degree in Virology from Complutense University of Madrid, and moved to Miami (Florida, United States) to join the Watkins laboratory at the University of Miami. She worked as a technician for two years, and then joined as a graduate student. In 2020, she obtained her Ph.D. in Biochemistry and Molecular Biology under Dr. David Watkins supervision. Her dissertation was entitled “Isolation of novel anti-SIV monoclonal antibodies from rhesus macaques”. Dr. Pedreño Lopez then conducted postdoctoral studies in Washington (District of Columba, United States), in which she focused on the effect of neutralizing and non-neutralizing antibodies against SIVmac239 in preventing infection in Indian rhesus macaques. Additionally, she also identified and characterized several neutralizing antibodies that could be used as treatment for yellow fever virus.
Dr. Pedreño joined IrsiCaixa in 2021. At the Immunology group (IgG), which is directed by Dr. Jorge Carrillo, she studies the mechanism that causes COVID-19 illness.